肝微粒體是體外研究一個(gè)化合物的代謝(酶抑制,清除率和代謝鑒定)以及藥物-藥物相互作用的主要工具。通常根據(jù)特定細(xì)胞色素酶的活性水平來(lái)選擇微粒體。 齊氏生物提供的肝細(xì)胞微粒體,每批產(chǎn)品都經(jīng)過(guò)嚴(yán)格的制備、檢測(cè),確保批次間穩(wěn)定性,然后于凍存管包裝,10 mg/管;-80℃保存,干冰運(yùn)輸。 用途:ADME及藥代動(dòng)力學(xué)檢測(cè)試驗(yàn) 種屬:人/大鼠/小鼠/兔/狗/豬/猴 /牛 規(guī)格:0.5ml 20mg/ml 運(yùn)輸:凍存管,干冰運(yùn)輸。 微粒體產(chǎn)品被SCI論文引用(部分):1.Metabolism of chicoric acid by rat liver microsomes and bioactivity comparisons of chicoric acid and its metabolitesQ Liu, Y Wang, CX Xiao, W Wu, X Liu - Food & function, 2015 - pubs.rsc.org… 11–14 Moreover, chicoric acid has showed anti-inflammatory, anti-bacterial, anti-HIVactivities, hypoglycemic and hepatocyte protective properties … Rat liver microsomeswere obtained from CHI Scientific, Inc. (Massachusetts, USA) 2.Hypoxia-triggered gene therapy: a new drug delivery system to utilize photodynamic-induced hypoxia for synergistic cancer therapyC Huang, J Zheng, D Ma, N Liu, C Zhu, J Li… - Journal of Materials …, 2018 - pubs.rsc.org… Rat liver microsomes were purchased from CHI Scientific (Jiangsu China … under hypoxic conditions(red curve); DDS in the presence of inactive rat liver microsomes and NADPH … 0 represent thefluorescence intensity of TAMRA after and before rat liver microsome addition under …附:產(chǎn)品介紹
江蘇齊氏生物科技有限公司
聯(lián)系商家時(shí)請(qǐng)?zhí)峒癱hemicalbook,有助于交易順利完成!
齊氏生物